Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 26, 2023

BUY
$135.66 - $197.02 $45,039 - $65,410
332 Added 26.62%
1,579 $242,000
Q4 2022

Jan 25, 2023

BUY
$118.38 - $210.04 $147,619 - $261,919
1,247 New
1,247 $0
Q2 2022

Jul 22, 2022

SELL
$117.13 - $176.59 $65,592 - $98,890
-560 Reduced 27.38%
1,485 $212,000
Q1 2022

Apr 22, 2022

BUY
$126.46 - $235.05 $258,610 - $480,677
2,045 New
2,045 $352,000
Q1 2021

Apr 23, 2021

SELL
$109.18 - $185.98 $252,314 - $429,799
-2,311 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$65.74 - $169.86 $151,925 - $392,546
2,311 New
2,311 $241,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Alpha Cubed Investments, LLC Portfolio

Follow Alpha Cubed Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Cubed Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Cubed Investments, LLC with notifications on news.